Evidence map›Paper›PMID 37244749›Full record

ArticleThe Prostate2023

Trends in prostate cancer incidence among Black men in the Caribbean and the United States.

Charnita Zeigler-Johnson, Alicia C McDonald, Paulo Pinheiro, Shannon Lynch, Emanuela Taioli, Shivam Joshi, Naomi Alpert, Jacqueline Baudin, Clarisse Joachim, Jacqueline Deloumeaux and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Prostate, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Observational
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 3 countries.

Charnita Zeigler-JohnsonDepartment of Medical Oncology, Division of Population Science, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-2641-7755
Alicia C McDonaldDepartment of Public Health Sciences, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania, USA.
Paulo PinheiroDepartment of Public Health Sciences, University of Miami, Miami, Florida, USA.
Shannon LynchFox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Emanuela TaioliMount Sinai, New York City, New York, USA.
Shivam JoshiMount Sinai, New York City, New York, USA.
Naomi AlpertMount Sinai, New York City, New York, USA.
Jacqueline BaudinUnité Fonctionnelle Recherche en Cancérologie UF3596, Centre Hospitalier Universitaire de Martinique, Fort-de-France, Martinique.
Clarisse JoachimRegistre Général des cancers de la Martinique UF1441, Centre Hospitalier Universitaire de Martinique, Fort-de-France, Martinique.
Jacqueline DeloumeauxRegistre Général des cancers de la Guadeloupe, Centre Hospitalier Universitaire de la Guadeloupe, Pointe-a-Pitre, Guadeloupe.
JoAnn OliverCapstone College of Nursing, University of Alabama, Tuscaloosa, Alabama, USA.
Bernard Bhakkan-MambirRegistre Général des cancers de la Guadeloupe, Centre Hospitalier Universitaire de la Guadeloupe, Pointe-a-Pitre, Guadeloupe.
Murielle Beaubrun-RenardRegistre Général des cancers de la Martinique UF1441, Centre Hospitalier Universitaire de Martinique, Fort-de-France, Martinique.
Angel G OrtizFox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Camille RaginFox Chase Cancer Center, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-0816-4942
Centre Hospitalier Universitaire de Martinique · MQFox Chase Cancer Center · USMount Sinai Hospital · USCentre Hospitalier Universitaire Pointe-à-Pitre · GPPennsylvania State University · USThomas Jefferson University · USUniversity of Alabama · USUniversity of Miami · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Eric Andrew Ross · 1985 to 2026
$138.8M
X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI Claudio Guillermo Giraudo · 1995 to 2026
$94.8M
Tumor Biology Research ProgramP30CA240139 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Stephen D. Nimer · 2019 to 2026
$24.1M
Disparities in molecular testing among non-small cell lung cancer patientsP20CA264076 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BENN, EMMA KATHERINE TARA · 2021 to 2024
$1.2M
The coordination plan and community needs assessmentP20CA210294 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI BAILEY, ALTHEA ELAINE, BECK, JOHN ROBERT · 2017 to 2018
$548k
NCI NIH HHS P20 CA210294NCI NIH HHS P20 CA264076NCI NIH HHS P30 CA006927NCI NIH HHS P30 CA056036NCI NIH HHS P30 CA240139NIH HHS P20 CA210294NIH HHS P20 CA264076NIH HHS P30 CA006927NIH HHS P30 CA056036NIH HHS P30 CA240139
6 · The paper itself

Abstract

backgroundProstate cancer incidence is highest for Black men of the African diaspora in the United States and Caribbean. Recent changes in recommendations for prostate cancer screening have been shown to decrease overall prostate cancer incidence and increase the likelihood of late stage disease. However, it is unclear how trends in prostate cancer characteristics among high risk Black men differ by geographic region during the changes in screening recommendations.

methodsIn this study, we used population-based prostate cancer registry data to describe age-adjusted prostate cancer incidence trends from 2008 to 2015 among Black men from six geographic regions. We obtained data on incident Black prostate cancer patients from six cancer registries (in the United States: Florida, Alabama, Pennsylvania, and New York; and in the Caribbean: Guadeloupe and Martinique). After age standardization, we used descriptive analyses to compare the demographics and tumor characteristics by cancer registry site. The Joinpoint regression program was used to compare the trends in incidence by site.

resultsA total of 59,246 men were analyzed. We found the highest incidence rates (per 100,000) for prostate cancer in the Caribbean countries (181.99 in Martinique and 176.62 in Guadeloupe) and New York state (178.74). Incidence trends decreased significantly over time at all sites except Martinique, which also showed significantly increasing rates of late stage (III/IV) and Gleason score 7+ tumors.

conclusionsWe observed significant differences in prostate cancer incidence trends among Black men after major changes prostate screening recommendations. Future studies will examine the factors that differentially influence prostate cancer trends among the African diaspora.

Indexed as

Prostatic NeoplasmsCaribbean RegionEarly Detection of CancerHumansIncidenceMaleProstate-Specific AntigenUnited StatesProstate-Specific AntigenBlack menCaribbeanincidence ratesprostate cancer

Identifiers

PMID37244749
PMCPMC11256998
OpenAlexW4378514926

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.